Macrogenics | 1.81 +0.11 +6.47% | ||
| MGNX | |||
| 高 1.81 | 开 1.71 | 量 79.38万股 | 总市值 1.14亿 |
| 低 1.70 | 换 1.25% | 额 139.21万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
OYang
2025-11-13 18:34
#药闻简讯# $Macrogenics(MGNX)$ 公司终止了 lorigerlimab（抗 PD-1 x CTLA-4 双特异性抗体）在前列腺癌领域的研发；其在卵巢癌领域的研发仍在继续。
10赞
Macrogenics(MGNX)
2025-12-11 05:15
$Macrogenics(MGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002051299-25-000004 Size: 5 KB 网页链接
Macrogenics(MGNX)
01-07 08:35
$Macrogenics(MGNX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-26-001469 Act: 34 Size: 9 KB 网页链接
Macrogenics(MGNX)
2025-11-13 05:16
$Macrogenics(MGNX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001125345-25-000108 Act: 34 Size: 5 MB 网页链接
Macrogenics(MGNX)
2025-11-13 05:16
$Macrogenics(MGNX)$ 8-K Current report, item 2.02 Accession Number: 0001125345-25-000109 Act: 34 Size: 440 KB 网页链接
Macrogenics(MGNX)
2025-11-21 05:05
$Macrogenics(MGNX)$ 8-K Current report, item 5.02 Accession Number: 0001125345-25-000111 Act: 34 Size: 139 KB 网页链接
Macrogenics(MGNX)
2025-11-13 04:35
$Macrogenics(MGNX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000814133-25-000105 Act: 34 Size: 6 KB 网页链接